vs
MID PENN BANCORP INC（MPB）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
MID PENN BANCORP INC的季度营收约是RHYTHM PHARMACEUTICALS, INC.的1.0倍（$62.0M vs $60.1M），MID PENN BANCORP INC净利率更高（31.4% vs -92.6%，领先123.9%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（83.8% vs 30.8%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（43.8% vs 21.1%）
该资料实际介绍的是1973年成立于新泽西州切里希尔的商业银行，该银行在2007年被多伦多道明银行收购，并入其旗下的TD Banknorth，之后TD Banknorth统一更名为TD银行。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
MPB vs RYTM — 直观对比
营收规模更大
MPB
是对方的1.0倍
$60.1M
营收增速更快
RYTM
高出53.0%
30.8%
净利率更高
MPB
高出123.9%
-92.6%
两年增速更快
RYTM
近两年复合增速
21.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $62.0M | $60.1M |
| 净利润 | $19.4M | $-55.6M |
| 毛利率 | — | 88.1% |
| 营业利润率 | 43.6% | -87.1% |
| 净利率 | 31.4% | -92.6% |
| 营收同比 | 30.8% | 83.8% |
| 净利润同比 | 47.0% | — |
| 每股收益（稀释后） | $0.83 | $-0.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MPBRYTM
| Q1 26 | — | $60.1M | ||
| Q4 25 | $62.0M | $57.3M | ||
| Q3 25 | $61.8M | $51.3M | ||
| Q2 25 | $54.3M | $48.5M | ||
| Q1 25 | $47.7M | $32.7M | ||
| Q4 24 | $47.4M | $41.8M | ||
| Q3 24 | $45.3M | $33.3M | ||
| Q2 24 | $44.1M | $29.1M |
净利润MPBRYTM
| Q1 26 | — | $-55.6M | ||
| Q4 25 | $19.4M | $-47.5M | ||
| Q3 25 | $18.3M | $-52.9M | ||
| Q2 25 | $4.8M | $-46.6M | ||
| Q1 25 | $13.7M | $-49.5M | ||
| Q4 24 | $13.2M | $-43.3M | ||
| Q3 24 | $12.3M | $-43.6M | ||
| Q2 24 | $11.8M | $-32.3M |
毛利率MPBRYTM
| Q1 26 | — | 88.1% | ||
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% |
营业利润率MPBRYTM
| Q1 26 | — | -87.1% | ||
| Q4 25 | 43.6% | -82.2% | ||
| Q3 25 | 39.3% | -102.6% | ||
| Q2 25 | 7.9% | -93.4% | ||
| Q1 25 | 35.2% | -143.7% | ||
| Q4 24 | 34.1% | -98.6% | ||
| Q3 24 | 32.8% | -132.0% | ||
| Q2 24 | 32.4% | -139.2% |
净利率MPBRYTM
| Q1 26 | — | -92.6% | ||
| Q4 25 | 31.4% | -83.0% | ||
| Q3 25 | 29.6% | -103.1% | ||
| Q2 25 | 8.8% | -96.1% | ||
| Q1 25 | 28.8% | -151.4% | ||
| Q4 24 | 27.9% | -103.6% | ||
| Q3 24 | 27.1% | -131.2% | ||
| Q2 24 | 26.7% | -110.9% |
每股收益（稀释后）MPBRYTM
| Q1 26 | — | $-0.83 | ||
| Q4 25 | $0.83 | $-0.73 | ||
| Q3 25 | $0.79 | $-0.82 | ||
| Q2 25 | $0.22 | $-0.75 | ||
| Q1 25 | $0.71 | $-0.81 | ||
| Q4 24 | $0.72 | $-0.71 | ||
| Q3 24 | $0.74 | $-0.73 | ||
| Q2 24 | $0.71 | $-0.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $340.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $814.1M | $122.9M |
| 总资产 | $6.1B | $442.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MPBRYTM
| Q1 26 | — | $340.6M | ||
| Q4 25 | — | $388.9M | ||
| Q3 25 | — | $416.1M | ||
| Q2 25 | — | $291.0M | ||
| Q1 25 | — | $314.5M | ||
| Q4 24 | — | $320.6M | ||
| Q3 24 | — | $298.4M | ||
| Q2 24 | — | $319.1M |
股东权益MPBRYTM
| Q1 26 | — | $122.9M | ||
| Q4 25 | $814.1M | $139.1M | ||
| Q3 25 | $796.3M | $148.8M | ||
| Q2 25 | $775.7M | $-11.9M | ||
| Q1 25 | $667.9M | $18.9M | ||
| Q4 24 | $655.0M | $21.7M | ||
| Q3 24 | $573.1M | $11.2M | ||
| Q2 24 | $559.7M | $39.3M |
总资产MPBRYTM
| Q1 26 | — | $442.3M | ||
| Q4 25 | $6.1B | $480.2M | ||
| Q3 25 | $6.3B | $506.9M | ||
| Q2 25 | $6.4B | $372.7M | ||
| Q1 25 | $5.5B | $386.7M | ||
| Q4 24 | $5.5B | $392.3M | ||
| Q3 24 | $5.5B | $363.6M | ||
| Q2 24 | $5.4B | $381.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $80.0M | — |
| 自由现金流经营现金流 - 资本支出 | $71.8M | — |
| 自由现金流率自由现金流/营收 | 115.8% | — |
| 资本支出强度资本支出/营收 | 13.3% | — |
| 现金转化率经营现金流/净利润 | 4.12× | — |
| 过去12个月自由现金流最近4个季度 | $132.1M | — |
8季度趋势，按日历期对齐
经营现金流MPBRYTM
| Q1 26 | — | — | ||
| Q4 25 | $80.0M | $-25.4M | ||
| Q3 25 | $26.3M | $-26.6M | ||
| Q2 25 | $29.0M | $-23.3M | ||
| Q1 25 | $11.5M | $-40.4M | ||
| Q4 24 | $51.4M | $-18.8M | ||
| Q3 24 | $16.9M | $-25.2M | ||
| Q2 24 | $18.0M | $-29.1M |
自由现金流MPBRYTM
| Q1 26 | — | — | ||
| Q4 25 | $71.8M | — | ||
| Q3 25 | $24.3M | — | ||
| Q2 25 | $27.2M | — | ||
| Q1 25 | $8.8M | — | ||
| Q4 24 | $44.5M | — | ||
| Q3 24 | $16.8M | — | ||
| Q2 24 | $17.7M | — |
自由现金流率MPBRYTM
| Q1 26 | — | — | ||
| Q4 25 | 115.8% | — | ||
| Q3 25 | 39.4% | — | ||
| Q2 25 | 50.1% | — | ||
| Q1 25 | 18.4% | — | ||
| Q4 24 | 93.8% | — | ||
| Q3 24 | 37.1% | — | ||
| Q2 24 | 40.2% | — |
资本支出强度MPBRYTM
| Q1 26 | — | — | ||
| Q4 25 | 13.3% | — | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | 5.7% | — | ||
| Q4 24 | 14.6% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.7% | — |
现金转化率MPBRYTM
| Q1 26 | — | — | ||
| Q4 25 | 4.12× | — | ||
| Q3 25 | 1.44× | — | ||
| Q2 25 | 6.08× | — | ||
| Q1 25 | 0.84× | — | ||
| Q4 24 | 3.88× | — | ||
| Q3 24 | 1.37× | — | ||
| Q2 24 | 1.53× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
